0000905148-24-001615.txt : 20240523
0000905148-24-001615.hdr.sgml : 20240523
20240523191506
ACCESSION NUMBER: 0000905148-24-001615
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240521
FILED AS OF DATE: 20240523
DATE AS OF CHANGE: 20240523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Strobeck Matthew
CENTRAL INDEX KEY: 0001377832
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39659
FILM NUMBER: 24980350
MAIL ADDRESS:
STREET 1: C/O METABOLIX, INC.
STREET 2: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODESIX INC
CENTRAL INDEX KEY: 0001439725
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 203986492
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 303-417-0500
MAIL ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
form4.xml
X0508
4
2024-05-21
0001439725
BIODESIX INC
BDSX
0001377832
Strobeck Matthew
919 WEST DILLON RD
LOUISVILLE
CO
80027
true
false
Common Stock
2024-05-23
4
M
0
52160
A
85673
I
By Birchview Capital Separately Managed Account
Common Stock
2024-05-23
4
M
0
295680
A
2570879
I
By Birchview Fund LLC
Common Stock
2542928
D
Common Stock
119003
I
By UTMA Account
Common Stock
119003
I
By UTMA Account
Common Stock
119003
I
By UTMA Account
Common Stock
119003
I
By UTMA Account
Common Stock
40665
I
By Clajer Capital LLC
Restricted Stock Units
2024-05-21
4
A
0
53726
0
A
Common Stock
53726
53726
D
Stock Options (Right to Buy)
1.57
2024-05-21
4
A
0
37050
0
A
2034-05-20
Common Stock
37050
37050
D
Series A Non-Voting Convertible Preferred Stock
2024-05-23
4
M
0
1304
0
D
Common Stock
52160
0
I
By Birchview Capital Separately Managed Account
Series A Non-Voting Convertible Preferred Stock
2024-05-23
4
M
0
7392
0
D
Common Stock
295680
0
I
By Birchview Fund LLC
The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.
The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The Reporting Person is an affiliate of Clajer Capital LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Common Stock.
These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
/s/ Robin H. Cowie as Attorney-in-Fact for Matthew Strobeck
2024-05-23